At the ISPOR Europe 2024 Conference, CapeStart, Inc. unveiled MadeAi™, a generative AI-powered platform designed to revolutionize the synthesis of clinical information. The platform’s first solution, MadeAi-LR, enhances the efficiency of systematic literature reviews (SLRs), clinical evidence reports (CERs), meta-research,…
BrightHeart, an innovator in AI technology for obstetrics and pediatric cardiology, has received FDA 510(k) clearance for its first AI-driven software, which aims to revolutionize prenatal ultrasound evaluations of the fetal heart. This breakthrough comes at a critical time, as…
Cancer Targeted Technology (CTT), a Seattle-based biotechnology company focused on cancer diagnostics and therapies, announced that the National Cancer Institute has awarded the Phase I portion ($400K) of a fast-track Phase I/II Small Business Innovation Research (SBIR) grant to support…
Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that clinical biomarker data from the ADI-001 Phase 1 GLEAN trial will be presented in…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leader in RNA interference (RNAi) therapeutics, today announced positive new results from its ongoing Phase 1 clinical trial of nucresiran (formerly ALN-TTRsc04), an investigational RNAi therapeutic targeting transthyretin (TTR) for the treatment of ATTR…
Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company, is expanding its presence in New Jersey by offering a wider range of affordable health insurance plans through the ACA marketplace in 2025. This expansion will make Oscar’s personalized healthcare…
Alpha Cognition Inc. (NASDAQ: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing therapies for neurodegenerative diseases, has released its financial results for the second quarter and six months ending September 30, 2024, along with a corporate update. Key Updates:…
Universal Health Services (UHS) (NYSE: UHS) has been named a Champion of Board Diversity by The Forum of Executive Women, the leading women’s organization in the Greater Philadelphia Region. This prestigious recognition honors public companies in the region with at…
Cardinal Health recently celebrated the grand opening of its new Scientific Services Chemistry Center in Mansfield, Massachusetts. This state-of-the-art, FDA-regulated laboratory spans nearly 26,000 square feet and is designed to accelerate product development, enhance manufacturing efficiency, and ensure top-tier regulatory…
In the fast-paced and high-stakes environment of the operating room (OR), precision and protection are critical. That’s why Cardinal Health’s Surgical Drapes and Gowns team focuses on creating products designed to safeguard both clinicians and patients during medical procedures. Every…
Cardinal Health (NYSE: CAH) announced the signing of definitive agreements to acquire two key companies that align with its growth strategy and will enhance patient care. The acquisitions include a majority stake in GI Alliance (GIA), a leading gastroenterology management…
Meridian Health Plan of Illinois, a provider of managed care services for children, families, and individuals with complex medical needs, has expanded its telehealth program with Blueberry Pediatrics. Initially launched as a pilot in March 2024, the program will now…